Neonatal thyrotoxicosis.
作者信息
Hopton D S, Wade J S
出版信息
Proc R Soc Med. 1969 Aug;62(8):817. doi: 10.1177/003591576906200817.
Abstract
摘要
相似文献
1
Neonatal thyrotoxicosis.新生儿甲状腺毒症
Proc R Soc Med. 1969 Aug;62(8):817. doi: 10.1177/003591576906200817.
2
Prediction of the long-term results of antithyroid drug therapy for thyrotoxicosis.甲状腺毒症抗甲状腺药物治疗长期疗效的预测
J Clin Endocrinol Metab. 1970 Apr;30(4):540-3. doi: 10.1210/jcem-30-4-540.
3
Iodine distribution in thyroid tissue taken from hyperthyroid patients treated with Lugol's solution or carbimazole.来自接受卢戈氏溶液或卡比马唑治疗的甲状腺功能亢进患者的甲状腺组织中的碘分布。
Rev Eur Etud Clin Biol. 1971 Aug-Sep;16(7):662-7.
4
Thyrotoxicosis in pregnancy.
Lancet. 1972 Apr 22;1(7756):886-7.
5
Combined carbimazole-131-I treatment for thyrotoxicosis.卡比马唑与碘-131联合治疗甲状腺毒症
Scott Med J. 1972 Feb;17(2):57-61. doi: 10.1177/003693307201700203.
6
Prediction of the long-term results of antithyroid drug therapy for thyrotoxicosis.甲状腺毒症抗甲状腺药物治疗的长期结果预测
J Clin Endocrinol Metab. 1969 Jul;29(7):998-1001. doi: 10.1210/jcem-29-7-998.
7
Effect of pretreatment with carbimazole in patients with thyrotoxicosis subsequently treated with radioactive iodine.卡比马唑预处理对随后接受放射性碘治疗的甲状腺毒症患者的影响。
Br Med J. 1969 Aug 23;3(5668):443-4. doi: 10.1136/bmj.3.5668.443.
8
Thyroidal suppressibility after stopping long-term treatment of thyrotoxicosis with anti-thyroid drugs.停用抗甲状腺药物长期治疗甲状腺毒症后的甲状腺抑制性
Metabolism. 1969 Jan;18(1):58-62. doi: 10.1016/0026-0495(69)90133-4.
9
Neonatal thyrotoxicosis.新生儿甲状腺毒症
Med J Aust. 1973 Sep 1;2(9):432-4. doi: 10.5694/j.1326-5377.1973.tb115207.x.
10
[Antithyroid agents. 15].[抗甲状腺药物。15]
Pharm Prax. 1967;9:258-64.
本文引用的文献
1
CONGENITAL THYROTOXICOSIS.先天性甲状腺毒症
Lancet. 1964 Sep 5;2(7358):497-8. doi: 10.1016/s0140-6736(64)90452-0.
2
Studies on the thyroid activator of hyperthyroidism.关于甲状腺功能亢进症的甲状腺激活剂的研究。
J Clin Endocrinol Metab. 1961 Jun;21:635-47. doi: 10.1210/jcem-21-6-635.
Zotero 插件